Skip to main navigation Skip to main content

Clin Mol Hepatol : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Articles

Correspondence

Incorporating chronic kidney disease into the cost-effectiveness of MASLD treatment

Eileen L. Yoon1,2, Jeong-Yeon Cho3, Mimi Kim4, Huiyul Park5, Hye-Lin Kim6orcid , Dae Won Jun1,2
Published online: February 2, 2026
1Department of Internal Medicine, Hanyang University Hospital, Hanyang University College of Medicine, Seoul, Republic of Korea
2Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea
3Department of Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah, USA
4Department of Radiology, Hanyang University College of Medicine, Seoul, Republic of Korea
5Department of Family Medicine, Myoungji Hospital, Hanyang University College of Medicine, Goyang, Republic of Korea
6Department of Pharmacy, Sahmyook University College of Pharmacy, Seoul, Republic of Korea
Corresponding author:  Hye-Lin Kim, Tel: +82-2-3399-1625, Fax: +82-2-3399-1617, 
Email: maristella76@tistory.com
Dae Won Jun, Tel: +82-2-2290-8338, Fax: +82-2-972-0068, 
Email: noshin@hanyang.ac.kr

Eileen L. Yoon, Jeong-Yeon Cho, Mimi Kim and Huiyul Park contributed equally to this study as co-first authors.
Received: 20 January 2026   • Accepted: 24 January 2026
  • 631 Views
  • 39 Download
  • 0 Crossref
  • 0 Scopus

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

Include:

Incorporating chronic kidney disease into the cost-effectiveness of MASLD treatment
Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:
Include:
Incorporating chronic kidney disease into the cost-effectiveness of MASLD treatment
Close